EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62015CN0296
Case C-296/15: Request for a preliminary ruling from the Državna revizijska komisija za revizijo postopkov oddaje javnih naročil (Slovenia) lodged on 18 June 2015 — Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota
Case C-296/15: Request for a preliminary ruling from the Državna revizijska komisija za revizijo postopkov oddaje javnih naročil (Slovenia) lodged on 18 June 2015 — Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota
Case C-296/15: Request for a preliminary ruling from the Državna revizijska komisija za revizijo postopkov oddaje javnih naročil (Slovenia) lodged on 18 June 2015 — Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota
OJ C 346, 19.10.2015, p. 2–2
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
19.10.2015 |
EN |
Official Journal of the European Union |
C 346/2 |
Request for a preliminary ruling from the Državna revizijska komisija za revizijo postopkov oddaje javnih naročil (Slovenia) lodged on 18 June 2015 — Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota
(Case C-296/15)
(2015/C 346/02)
Language of the case: Slovenian
Referring court
Državna revizijska komisija za revizijo postopkov oddaje javnih naročil
Parties to the main proceedings
Applicant: Medisanus d.o.o.
Defendant: Splošna Bolnišnica Murska Sobota
Question referred
1) |
Must Directive 2004/18/EC (1), in particular Article 23(2), Article 23(8) and Article 2 thereof, read in conjunction with
|
be interpreted as precluding a specification that industrially manufactured medicinal products must be ‘obtained from Slovenian plasma’, (a specification based on the domestic legislation of the Republic of Slovenia, namely Article 6(71) of the ZZdr-2)?
(1) Directive 2004/18/EC of the European Parliament and of the Council of 31 March 2004 on the coordination of procedures for the award of public works contracts, public supply contracts and public service contracts (OJ 2004 L 134, p. 114).
(2) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67).
(3) Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC (OJ 2003 L 33, p. 30).